title: [Treatment of maxillofacial vascular malformation by arterial embolism and application of sclerosing agent].
abstract: 30 cases of large cavernous and racemose hemangioma of the maxillofacial were treated selectively with arterial embolism of the tumor and inject Xiaozhiling into the tumor, from November 1990 to November 1993. This method has exact effect either to racemose or to cavernous hemangioma, without facial defect and functional damage. All the patients were followed up 6 months to 3 years. 27 cases were cured, 1 failed, 1 gave up treatment, 1 died of complication. Its mechanism, indications, prevention of complications and recurrence were discussed.
authors.affiliation: Lin Yi Tumor Hospital, Shandong.
authors.forename: Z
authors.initials: Z
authors.lastname: Qin
authors.forename: A
authors.initials: A
authors.lastname: Lin
authors.forename: Z
authors.initials: Z
authors.lastname: Xin
mesh_terms: D000293:Adolescent; D000328:Adult; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D005153:Facial Neoplasms / Q000628:therapy*; D005158:Facial Paralysis / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D005781:Gelatin Sponge, Absorbable / Q000627:therapeutic use; D006391:Hemangioma / Q000628:therapy; D006392:Hemangioma, Cavernous / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000628:therapy*; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use; D015911:Sclerotherapy
chemical_list: D012597:Sclerosing Solutions